18 Feb 2022 --- Royal DSM has announced two of its probiotic strains received New Dietary Ingredient (NDI) status from the US Food and Drug Administration (FDA), which is “good news” for DSM’s partners. The Netherlands-based health giant’s Lactobacillus rhamnosus 19070-2 and Lactobacillus reuteri 12246-CU signal continued investment in gut health solutions.
